Product Information

DEXTROAMP-AMPHET ER 5 MG CAP is a generic product labeled by Rhodes Pharmaceuticals L.P., priced at $0.4793 per EA under NDC 42858005501. Its NADAC has been published 358 times since Oct 16, 2019.

FDA first approved this application on May 17, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for DEXTROAMP-AMPHET ER 5 MG CAP has been published 358 times since Oct 16, 2019, and over the history we have for it it has declined 64.8%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.